[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Voll Medical Technologies Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":62},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100650246","voll-non-degradable-shoulder-spacer-fih-study-100650246",false,"NCT07745647","Voll Non-Degradable Shoulder Spacer FIH Study","A Single-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Non-Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears","Inclusion Criteria:\n\n* Full thickness MRCT.\n* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.\n\nExclusion Criteria:\n\n* Documented evidence of a history of drug\u002Falcohol abuse within 1 year of enrollment.\n* Concurrent participation in any other investigational clinical study.","ALL","50 Years",{"count":19,"type":20},10,"ESTIMATED","INTERVENTIONAL",[23],"NA","The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).",[26,27],"Massive Rotator Cuff Tears","Massive Rotator Cuff Tear","NOT_YET_RECRUITING","2026-07-29",{"date":31,"type":32},"2026-08-04","ACTUAL",{"date":34,"type":20},"2026-09",{"date":36,"type":20},"2028-09",{"name":38,"class":39},"Voll Medical Technologies Ltd.","INDUSTRY",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},"100608968","voll-degradable-shoulder-spacer-fih-study-100608968","NCT07208448","Voll Degradable Shoulder Spacer FIH Study","A Multi-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears","Main Inclusion Criteria:\n\n* Full thickness MRCT.\n* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.\n\nMain Exclusion Criteria:\n\n* Documented evidence of a history of drug\u002Falcohol abuse within 1 year of enrollment.\n* Concurrent participation in any other investigational clinical study.",{"count":49,"type":20},20,[23],"The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).",[27],"RECRUITING",{"date":55,"type":32},"2026-07-30",{"date":57,"type":32},"2025-12-09",{"date":59,"type":20},"2027-12-31",{"name":38,"class":39},4,""]